These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12855941)

  • 1. Maternally acquired varicella-zoster virus antibodies disappear at 6 months of age in prematurely born children.
    Akisu M; Yalaz M; Aksu G; Arslanoglu S; Genel F; Kutukculer N; Kultursay N
    Panminerva Med; 2003 Jun; 45(2):155-6. PubMed ID: 12855941
    [No Abstract]   [Full Text] [Related]  

  • 2. [Varicella-zoster virus infection and the serologic determination of first-infection immunity].
    Schneweis KE; Krentler C; Wolff MH
    Dtsch Med Wochenschr; 1985 Mar; 110(12):453-7. PubMed ID: 2983965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of antibody formation in intrauterine varicella virus infection.
    Trlifajová J
    Acta Virol; 1991 May; 35(3):295-7. PubMed ID: 1683137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of varicella zoster virus in pregnant patients].
    Sauerbrei A; Sonntag S; Wutzler P
    Zentralbl Gynakol; 1990; 112(4):223-6. PubMed ID: 2159681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Varicella zoster virus infections in pregnancy].
    Sauerbrei A; Wutzler P
    Zentralbl Gynakol; 1992; 114(5):259-64. PubMed ID: 1320803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella-zoster virus infection in pregnancy.
    Enders G
    Prog Med Virol; 1984; 29():166-96. PubMed ID: 6322232
    [No Abstract]   [Full Text] [Related]  

  • 7. [Varicella-zoster virus infections. 1: Chickenpox and shingles. Treatment and prevention].
    Wassilew SW
    MMW Fortschr Med; 2006; Spec no.1():1-5; quiz 6. PubMed ID: 16872125
    [No Abstract]   [Full Text] [Related]  

  • 8. Difficulty in determining varicella-zoster immune status in pregnant women.
    Le CT; Lipson M
    Pediatr Infect Dis J; 1989 Sep; 8(9):650-1. PubMed ID: 2552391
    [No Abstract]   [Full Text] [Related]  

  • 9. Two cases of disseminated cutaneous herpes zoster in infants after intrauterine exposure to varicella-zoster virus.
    Chiang CP; Chiu CH; Huang YC; Lin TY
    Pediatr Infect Dis J; 1995 May; 14(5):395-7. PubMed ID: 7638019
    [No Abstract]   [Full Text] [Related]  

  • 10. Human herpes viruses in pregnancy: cytomegalovirus, Epstein-Barr virus, and varicella zoster virus.
    Hollier LM; Grissom H
    Clin Perinatol; 2005 Sep; 32(3):671-96. PubMed ID: 16085026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplacental immunity to varicella-zoster virus in extremely low birthweight infants.
    Mendez DB; Sinclair MB; Garcia S; Chou T; Meadow W
    Am J Perinatol; 1992 Jul; 9(4):236-8. PubMed ID: 1320886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The study of the occurrence of precipitation antibodies to varicella-zoster (VZ) virus in healthy and sick children up to one year of age in relation to their transplacental transfer.
    Trlifajová J; Hájková S; Ryba M; Sourek J; Svandová E; Seeman J
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(4):486-92. PubMed ID: 4344650
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age.
    Plans P; Costa J; Espuñes J; Plasència A; Salleras L
    BJOG; 2007 Sep; 114(9):1122-7. PubMed ID: 17666097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of maternal varicella-zoster virus infection on the outcome of pregnancy and the analysis of transplacental virus transmission.
    Trlifajová J; Benda R; Benes C
    Acta Virol; 1986 May; 30(3):249-55. PubMed ID: 2874730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenitally acquired herpes zoster infection in a newborn.
    Mogami S; Muto M; Mogami K; Asagami C
    Dermatology; 1997; 194(3):276-7. PubMed ID: 9187848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of the complement-fixing antibody response for varicella-zoster virus in patients with herpes zoster].
    Trivello R; Peserico A; Moschen ME; Romano M
    Ann Sclavo; 1977; 19(6):1133-43. PubMed ID: 218503
    [No Abstract]   [Full Text] [Related]  

  • 17. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
    Heininger U; Desgrandchamps D; Schaad UB
    Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns.
    Leineweber B; Grote V; Schaad UB; Heininger U
    Pediatr Infect Dis J; 2004 Apr; 23(4):361-3. PubMed ID: 15071296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
    Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
    Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.